SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Salary: USD 326,300 - 449,240 / annual
Recursion Pharmaceuticals, a clinical-stage TechBio company, is seeking a Vice President of Medical Affairs to build and lead the Medical Affairs strategy across its advancing clinical portfolio. Reporting to the Chief Medical Officer, you will shape how Recursion translates breakthrough science, clinical data, real-world evidence, and AI-enabled insights into meaningful impact for patients, clinicians, investigators, and health systems.
You will develop and lead integrated Medical Affairs strategies for priority assets in oncology, rare disease, immunology, and other therapeutic areas with significant unmet need. Key responsibilities include:
• Develop comprehensive Medical Affairs strategies covering scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, and launch readiness.
• Provide cross-functional Medical Affairs support on asset teams, partnering with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development.
• Build evidence-generation plans supporting asset differentiation, patient benefit, clinical adoption, and value demonstration, including real-world evidence, HEOR, epidemiology, natural history, burden of disease, treatment patterns, and outcomes-focused studies.
• Translate external insights from healthcare professionals, investigators, patient communities, payers, health systems, and scientific leaders into actionable recommendations for development strategy, trial design, endpoints, and education needs.
• Lead scientific engagement strategy with key opinion leaders, digital opinion leaders, investigators, cooperative groups, patient advocacy organizations, and professional societies through compliant, high-quality scientific exchange.
• Lead congress and conference strategy for priority programs, including planning and execution for major scientific meetings such as ASCO, ESMO, AACR, and AAN; partner on abstracts, presentations, scientific narratives, medical booths, and KOL engagement.
• Partner with Recursion's data science, platform, and Decision Science teams to explore responsible use of AI-enabled approaches for medical insights, evidence synthesis, stakeholder mapping, scientific communication, and measurement of medical impact.
• Establish medical communication strategy for assigned assets, including publications, congress abstracts and presentations, lexicon, scientific platform, FAQs, medical information content, and internal scientific training.
• Design and build a structured, scalable Medical Affairs organization as the portfolio matures, including fit-for-purpose capabilities across medical strategy, field medical, medical communications, medical information, evidence generation, congress planning, insights, and medical excellence.
• Establish governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes enabling Medical Affairs to support growth from clinical-stage development through potential launch readiness.
You will join an empowered, execution-minded Clinical Development organization and work closely with leaders across Development, Regulatory, Development Sciences, Clinical Operations, Data Science, Biology, Chemistry, Portfolio Strategy, Communications, Legal/Compliance, and future commercialization functions.
Recursion is a NASDAQ-listed clinical-stage TechBio company advancing a differentiated investigational medicine portfolio across oncology, rare disease, neuroscience, immunology, and other therapeutic areas. The Recursion OS is an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. The company maintains offices in Salt Lake City, New York, Montréal, and London.
REQUIREMENTS:
• Advanced clinical or scientific degree required; MD, DO, PharmD, PhD, or equivalent advanced degree strongly preferred.
• 15+ years of biotech or pharmaceutical industry experience, including significant leadership experience in Medical Affairs.
• Experience building and leading Medical Affairs strategy for clinical-stage or launch-stage assets, ideally in oncology, rare disease, immunology, or other specialty therapeutic areas.
• Proven ability to lead integrated evidence planning, including RWE, HEOR, epidemiology, burden-of-disease, natural history, treatment-pattern, outcomes, and value-focused studies.
• Strong understanding of drug development from early clinical development through launch readiness and lifecycle planning, including how Medical Affairs contributes to trial design, endpoint strategy, external engagement, publications, and evidence generation.
• Demonstrated success in engaging KOLs, investigators, patient advocacy organizations, professional societies, payers/HTA stakeholders, and other external experts through compliant scientific exchange.
• Experience developing scientific platforms, publication plans, congress strategies, advisory boards, medical education initiatives, and medical information resources.
• Strong working knowledge of relevant compliance expectations, including scientific exchange, medical review, publication practices, advisory board governance, and interactions with healthcare professionals across the US and globally.
